🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the producers of Tylenol, alleging the firms hid potential risks that the drug presented to pediatric neurological development.

The lawsuit comes a month after President Donald Trump publicized an unverified association between using Tylenol - alternatively called paracetamol - during pregnancy and autism in young ones.

Paxton is suing the pharmaceutical giant, which formerly manufactured the medication, the exclusive pain medication suggested for women during pregnancy, and Kenvue, which presently makes it.

In a declaration, he said they "misled consumers by profiting off of pain and pushing pills ignoring the dangers."

The manufacturer says there is insufficient reliable data connecting acetaminophen to autism.

"These companies misled for generations, intentionally threatening millions to increase profits," Paxton, from the Republican party, declared.

Kenvue said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the likely effects that could have on the well-being of American women and children."

On its website, Kenvue also stated it had "consistently assessed the pertinent research and there is insufficient valid information that indicates a established connection between using paracetamol and autism."

Groups representing physicians and health professionals share this view.

The leading OB-GYN organization has said acetaminophen - the key substance in acetaminophen - is among limited choices for expectant mothers to manage discomfort and elevated temperature, which can present significant medical dangers if ignored.

"In more than two decades of investigation on the use of acetaminophen in pregnancy, zero credible investigations has conclusively proven that the usage of acetaminophen in any stage of pregnancy leads to neurological conditions in offspring," the organization said.

The court filing cites current declarations from the former administration in arguing the drug is allegedly unsafe.

Last month, Trump generated worry from public health officials when he instructed women during pregnancy to "struggle intensely" not to consume acetaminophen when ill.

The US Food and Drug Administration then published an announcement that physicians should consider limiting the usage of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism spectrum disorder in minors has not been established.

Health Secretary RFK Jr, who oversees the Food and Drug Administration, had promised in April to undertake "comprehensive study program" that would identify the cause of autism in a matter of months.

But specialists warned that identifying a sole reason of autism spectrum disorder - considered by experts to be the result of a complex mix of inherited and surrounding conditions - would be difficult.

Autism is a type of lifelong neurodivergence and disability that influences how persons perceive and relate to the surroundings, and is identified using physician assessments.

In his legal document, Paxton - aligned with the former president who is running for federal office - asserts the manufacturer and J&J "deliberately disregarded and attempted to silence the research" around paracetamol and autism spectrum disorder.

The lawsuit aims to force the corporations "destroy any promotional materials" that states Tylenol is reliable for women during pregnancy.

This legal action mirrors the grievances of a assembly of parents of minors with autism and ADHD who took legal action against the manufacturers of Tylenol in 2022.

A federal judge dismissed the lawsuit, stating investigations from the parents' expert witnesses was not conclusive.